A Single-Center, Randomized, Placebo-Controlled Study to Evaluate the Safety, Tolerability and Preliminary Efficacy of MN-001 (Tipelukast) in Idiopathic Pulmonary Fibrosis

Bascom, R., Hitz, K., Dimmock, A.E.F. · B22. EMERGING MANAGEMENT OF FIBROTIC ILDs · 2022